Clone Backtest Leaders — Top 10
Funds whose clone backtest holding each fund's top 10 positions, rebalanced quarterly since 2021, delivered the highest total return. Value weighted, one-quarter signal lag. Funds with less than 2 years of priced history are excluded.
Based on Q3 2026 13F filings · Top 10 · All rankings
| # | Fund | Total Return | Annualized | Sharpe (rf=0) | Win Rate | Max Drawdown | Clone Backtest |
|---|---|---|---|---|---|---|---|
| 1 | J.H. Whitney Equity Partners VII, LLC | +942.86% | +118.48% | 1.29 | 58.33% | 27.40% | View backtest |
| 2 | Index Venture Growth Associates III Ltd | +762.70% | +94.07% | 1.05 | 76.92% | 50.92% | View backtest |
| 3 | Oxbow Capital Management (HK) Ltd | +617.05% | +92.83% | 1.18 | 83.33% | 17.74% | View backtest |
| 4 | NetEase, Inc. | +566.01% | +79.22% | 0.92 | 69.23% | 40.03% | View backtest |
| 5 | Index Venture Associates VI Ltd | +561.47% | +78.84% | 0.87 | 76.92% | 55.91% | View backtest |
| 6 | FengHe Fund Management Pte. Ltd. | +524.92% | +84.19% | 2.16 | 83.33% | 23.05% | View backtest |
| 7 | Accel Leaders 4 Associates L.P. | +517.86% | +148.57% | 0.87 | 50.00% | 38.03% | View backtest |
| 8 | Blue Water Life Science Advisors, LP | +512.62% | +74.67% | 1.56 | 84.62% | 12.30% | View backtest |
| 9 | G2 Investment Partners Management LLC | +455.98% | +69.53% | 0.99 | 61.54% | 18.79% | View backtest |
| 10 | Donor Advised Charitable Giving, Inc. | +418.25% | +65.90% | 1.26 | 69.23% | 19.77% | View backtest |
About this ranking
13F filings disclose long U.S. equity positions quarterly with up to a 45-day delay; shorts and most non-U.S. holdings are not reported. Treat these lists as research starting points, not buy recommendations.